╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Hgb 8.0 g/dL or greater                            │ Bilirubin less than 1.5x upper limit of normal,    │
│                                                    │ AST less than 3x upper limit of normal, serum      │
│                                                    │ creatinine less than 1.5x normal and Hgb 8.0 g/dL  │
│                                                    │ or greater                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Severe intercurrent infection                      │ Severe intercurrent infection                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Life expectancy 6 weeks or greater                 │ Life expectancy 6 weeks or greater                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ The male partner should use a condom               │ Sexually active patients must be willing to        │
│                                                    │ utilize one of the more effective birth control    │
│                                                    │ methods for 6 months after the CTL infusion. The   │
│                                                    │ male partner should use a condom.                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ CMV seropositive                                   │ CMV seropositive                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of hypersensitivity reactions to murine    │ History of hypersensitivity reactions to murine    │
│ protein-containing products                        │ protein-containing products.                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known HIV positivity                               │ Known HIV positivity                               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnant or lactating                              │ Pregnant or lactating                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Sexually active patients must be willing to        │ Sexually active patients must be willing to        │
│ utilize one of the more effective birth control    │ utilize one of the more effective birth control    │
│ methods for 6 months after the CTL infusion        │ methods for 6 months after the CTL infusion. The   │
│                                                    │ male partner should use a condom.                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ serum creatinine less than 1.5x normal             │ Bilirubin less than 1.5x upper limit of normal,    │
│                                                    │ AST less than 3x upper limit of normal, serum      │
│                                                    │ creatinine less than 1.5x normal and Hgb 8.0 g/dL  │
│                                                    │ or greater                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Histopathological verification of glioblastoma     │ Histopathological verification of glioblastoma     │
│ multiforme (GBM: WHO grade IV) in remission (Group │ multiforme (GBM: WHO grade IV) in remission (Group │
│ A) or with active disease (Group B).               │ A) or with active disease (Group B).               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Informed consent explained to, understood by and   │ Informed consent explained to, understood by and   │
│ signed by patient/guardian. Patient/guardian given │ signed by patient/guardian. Patient/guardian given │
│ copy of informed consent.                          │ copy of informed consent.                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Bilirubin less than 1.5x upper limit of normal     │ Bilirubin less than 1.5x upper limit of normal,    │
│                                                    │ AST less than 3x upper limit of normal, serum      │
│                                                    │ creatinine less than 1.5x normal and Hgb 8.0 g/dL  │
│                                                    │ or greater                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient or parent/guardian capable of providing    │ Patient or parent/guardian capable of providing    │
│ informed consent                                   │ informed consent                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients should have been off other                │ Patients should have been off other                │
│ investigational antineoplastic therapy for one     │ investigational antineoplastic therapy for one     │
│ month prior to entry in this study.                │ month prior to entry in this study.                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ AST less than 3x upper limit of normal             │ Bilirubin less than 1.5x upper limit of normal,    │
│                                                    │ AST less than 3x upper limit of normal, serum      │
│                                                    │ creatinine less than 1.5x normal and Hgb 8.0 g/dL  │
│                                                    │ or greater                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Karnofsky/Lansky score 50 or greater               │ Karnofsky/Lansky score 50 or greater               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ CMV-positive GBM                                   │ CMV-positive GBM                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pulse oximetry of 90% or greater on room air       │ Pulse oximetry of 90% or greater on room air       │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛